Completion of a non-exclusive discount agreement according to section 130a 8 sgb v for the active ingredient naproxen esomeprazol atc m01ae52 f d z 01 09 2025 - 31 08 2027 plus extension option 1x12 months

Tender Organisation:

DAK health

Tender Sector:

IT-Software Tenders

Tender Service:

Worldwide

Tender Region:

Europe

Tender Country:

Germany

Tender CPV:

33600000 : Pharmaceutical products

Tender Document Type:

Tender Notice

Tender Description:

Completion of a non-exclusive discount agreement according to section 130a 8 sgb v for the active ingredient naproxen esomeprazol atc m01ae52 f d z 01 09 2025 - 31 08 2027 plus extension option 1x12 months The DAK health assumes that this procedure does not fall into the scope of the antitrust gever law due to a lack of selection decision and thus the possibility of discriminatory access of all pharmaceutical companies Regardless of this it automatically ends with the entry into force of the exclusive contract for Naproxen Esomeprazole ATC M01AE52 as a result of a formal award procedure according to the regulations of the 4th part of the GWB with one or more contractual partners In order to meet the diversity of the potential contractual partners within the framework of the approval model every pharmaceutical company will be enabled to conclude a framework contract at any time and on the same conditions during the contract term The contract documents required for this can be found on the online portal www dtvp de center on 5 1 11 mentioned link for download Requirements for the conclusion or the later accession to the contracts that have been entered for the first time on September 1st 2025 is the complete and timely sending of the following documents available for download under the link mentioned under 5 1 11 To the following department in the DAK-Gesundheit 1 Submission of the contract with name or company stamp by the prospect at the intended body 3 The completed systems 1 and 2 to the contract The prospect must enter the drugs for the above -mentioned active ingredient which should become subject to the contract The documents must be submitted by email at openhouse dak de DAK-Gesundheit Department of Medicines 0038 00 Nagelsweg 27-31 20097 Hamburg The Appendix 2 is expressly sent to the e-mail address openhouse dak de Contracts within the framework of this model and the above -mentioned active ingredient are completed for the first time with effect from September 1 2025 and end on August 31 2027 plus extension option 1x12 months Interested parties who want to become a contractual partner for this date must submit the above-mentioned documents by email until 5 The previous month The offer is to be submitted in text form as an electronic offer by email at openhouse dak de The submission of the offer by post is not provided in this procedure Please do not submit the offer via the German award portal An electronic input of the complete documents by email to the email address openhouse dak de is sufficient for the deadline Later joining is possible at any time In order to be able to join the 1st or 15th of the following month during the term of the contract the above documents regardless of the desired accession must be available to the DAK health up to the 5th month Here too it depends on the timely access by email at the DAK-G Example The accession desired by the bidder should be on July 15th Consequences the documents should be done until 05 06 Previous month Note The publication takes place here using the form for open procedures As already made clear this is not one - the announcement had to be used for technical reasons since there is no form suitable for admission procedures

Tender Bidding Type:

Click here for more details

Tender Notice No:

Click here for more details

Tender Document:

• 1 week to go
• 15 Days to go
• More than 15 days to go